# FDA Inspection 810872 - Biomat USA Inc - December 13, 2012

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e75e411e-1b6d-46a2-be2b-3fa90c6626b6
Source feed: FDA_Inspections

> FDA Inspection 810872 for Biomat USA Inc on December 13, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 810872
- Company Name: Biomat USA Inc
- Inspection Date: 2012-12-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1026886 - 2017-06-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a35638bc-9dc1-45ea-aae0-8ef00dc8b717)
- [FDA Inspection 711753 - 2011-03-03](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b5b82e16-9085-43d9-a8b3-ee5c6e733e1f)
- [FDA Inspection 570340 - 2009-02-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9b3acd8e-4ee5-4046-85c9-47a65ec12d38)

Company: https://www.keypedia.com/companies/biomat-usa-inc/4c5a1a72-8132-4254-891c-53d490dfeca8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d